Revisions and Refinements of the Diagnosis of Schizophrenia in DSM-5

Clinical Psychology: Science and Practice

Volumn 21, Issue 3, 2014, Pages 236-244

  Reddy, L Felice ^a,b   Horan, William P ^a,b   Green, Michael F ^a,b  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

DSM 5; Diagnosis; Schizophrenia

Indexed keywords

EID: 84908687363     PISSN: 09695893     EISSN: 14682850     Source Type: Journal    
DOI: 10.1111/cpsp.12071     Document Type: Article

References (54)

1. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
2. American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing.
3. Andreasen, N. C. (1997). The evolving concept of schizophrenia: From Kraepelin to the present and future. Schizophrenia Research, 28, 105-109. doi:10.1016/S0920-9964(97)00112-6
4. Barch, D. M., Bustillo, J., Gaebel, W., Gur, R., Heckers, S., Malaspina, D., Carpenter, W. T. (2013). Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: Relevance to DSM-5. Schizophrenia Research, 150, 15-20. doi:10.1016/j.schres.2013.04.027
5. Barch, D. M., & Ceaser, A. (2012). Cognition in schizophrenia: Core psychological and neural mechanisms. Trends in Cognitive Sciences, 16, 27-34
6. Barch, D. M., & Keefe, R. S. E. (2010). Anticipating DSM-V: Opportunities and challenges for cognition and psychosis. Schizophrenia Bulletin, 36, 43-47. doi:10.1016/j.tics.2011.11.015
7. Blanchard, J. J., & Cohen, A. S. (2006). The structure of negative symptoms within schizophrenia: Implications for assessment. Schizophrenia Bulletin, 32, 238-245. doi:10.1093/schbul/sbj013
8. Blanchard, J. J., Kring, A. M., Horan, W. P., & Gur, R. (2011). Toward the next generation of negative symptom assessments: The collaboration to advance negative symptom assessment in schizophrenia. Schizophrenia Bulletin, 37, 291-299. doi:10.1093/schbul/sbq104
9. Braff, D. L., Ryan, J., Rissling, A. J., & Carpenter, W. T. (2013). Lack of use in the literature from the last 20 years supports dropping traditional schizophrenia subtypes from DSM-5 and ICD-11. Schizophrenia Bulletin, 39, 751-753. doi:10.1093/schbul/sbt068
10. Buchanan, R. W., & Carpenter, W. T. (1994). Domains of psychopathology: An approach to the reduction of heterogeneity in schizophrenia. Journal of Nervous and Mental Disease, 182, 193-204. doi:10.1097/00005053-199404000-00001
11. Cannon, T. D., Cadenhead, K., Cornblatt, B., Woods, S. W., Addington, J., Walker, E., Heinssen, R. (2008). Prediction of psychosis in youth at high clinical risk: A multisite longitudinal study in North America. Archives of General Psychiatry, 65, 28-37. doi:10.1001/archgenpsychiatry.2007.3
12. Carpenter, W. T. (2013). RDoC and DSM-5: What's the fuss? Schizophrenia Bulletin, 39, 945-946. doi:10.1093/schbul/sbt101
13. Carpenter, W. T., & Tandon, R. (2013). Psychotic disorders in DSM-5: Summary of changes. Asian Journal of Psychiatry, 6, 266-268. doi:10.1016/j.ajp.2013.04.001
14. Carpenter, W. T., & van Os, J. (2011). Should attenuated psychosis syndrome be a DSM-5 diagnosis? American Journal of Psychiatry, 168, 460-463. doi:10.1176/appi.ajp.2011.10121816
15. Cheniaux, E., Landeira-Fernandez, J., Telles, L. L., Lessa, J. L. M., Dias, A., Duncan, T., & Versiani, M. (2008). Does schizoaffective disorder really exist? A systematic review of the studies that compared schizoaffective disorder with schizophrenia or mood disorders. Journal of Affective Disorders, 106, 209-217. doi:10.1016/j.jad.2007.07.009
16. Depp, C. A., Moore, D. J., Sitzer, D., Palmer, B. W., Eyler, L. T., Roesch, S., Jeste, D. V. (2007). Neurocognitive impairment in middle-aged and older adults with bipolar disorder: Comparison to schizophrenia and normal comparison subjects. Journal of Affective Disorders, 101, 201-209. doi:10.1016/j.jad.2006.11.022
17. First, M. B. (2009). Harmonisation of ICD-11 and DSM-V: Opportunities and challenges. British Journal of Psychiatry, 195, 382-390. doi:10.1192/bjp.bp.108.060822
18. Fusar-Poli, P., Bonoldi, I., Yung, A. R., Borgwardt, S., Kempton, M. J., Valmaggia, L., McGuire, P. (2012). Predicting psychosis: Meta-analysis of transition outcomes in individuals at high clinical risk. Archives of General Psychiatry, 69, 1-10. doi:10.1001/archgenpsychiatry.2011.1472
19. Gard, D. E., Kring, A. M., Gard, M. G., Horan, W. P., & Green, M. F. (2007). Anhedonia in schizophrenia: Distinctions between anticipatory and consummatory pleasure. Schizophrenia Research, 93, 253-260. doi:10.1016/j.schres.2007.03.008
20. Gee, D. G., & Cannon, T. D. (2011). Prediction of conversion to psychosis: Review and future directions. Revista Brasileira de Psiquiatria, 33(Suppl. 2), s129-s142. doi:10.1590/S1516-44462011000600002
21. Ginsberg, D. L., Schooler, N. R., Buckley, P. F., Harvey, P. D., & Weiden, P. J. (2005). Optimizing treatment of schizophrenia: Enhancing affective/cognitive and depressive functioning. CNS Spectrums, 10, 1-13.
22. Green, M. F., Kern, R. S., & Heaton, R. K. (2004). Longitudinal studies of cognition and functional outcome in schizophrenia: Implications for MATRICS. Schizophrenia Research, 72, 41-51. doi:10.1016/j.schres.2004.09.009
23. Heckers, S., Barch, D. M., Bustillo, J., Gaebel, W., Gur, R., Malaspina, D., Carpenter, W. T. (2013). Structure of the psychotic disorders classification in DSM 5. Schizophrenia Research, 150, 11-14. doi:10.1016/j.schres.2013.04.039
24. Heinrichs, R. W. (2005). The primacy of cognition in schizophrenia. American Psychologist, 60, 220-242. doi:10.1037/0003-066X.60.3.229
25. Hyman, S. E. (2007). Can neuroscience be integrated into the DSM-V? Nature Reviews Neuroscience, 8, 725-732. doi:10.1038/nrn2218
26. Ihara, K., Morgan, C., Fearon, P., Dazzan, P., Demjaha, A., Lloyd, T., Jones, P. B. (2009). The prevalence, diagnostic significance and demographic characteristics of Schneiderian first-rank symptoms in an epidemiological sample of first-episode psychoses. Psychopathology, 42, 81-91. doi:10.1159/000203340
27. Jansson, L. B., & Parnas, J. (2007). Competing definitions of schizophrenia: What can be learned from polydiagnostic studies? Schizophrenia Bulletin, 33, 1178-1200. doi:10.1093/schbul/sbl065
28. Keller, W. R., Fischer, B. A., & Carpenter, W. T. (2010). Revisiting the diagnosis of schizophrenia: Where have we been and where are we going? CNS Neuroscience & Therapeutics, 17, 83-88. doi:10.1111/j.1755-5949.2010.00229.x
29. Kirkpatrick, B., Fenton, W. S., Carpenter, W. T., & Marder, S. R. (2006). The NIMH-MATRICS consensus statement on negative symptoms. Schizophrenia Bulletin, 32, 214-219. doi:10.1093/schbul/sbj053
30. Kring, A. M., Gur, R. E., Blanchard, J. J., Horan, W. P., & Reise, S. P. (2013). Clinical Assessment Interview for Negative Symptoms (CAINS): Final development and validation. American Journal of Psychiatry, 170, 165-172. doi:10.1176/appi.ajp.2012.12010109
31. Kupfer, D. J., & Regier, D. A. (2011). Neuroscience, clinical evidence, and the future of psychiatric classification in DSM-5. American Journal of Psychiatry, 168, 672-674. doi:10.1176/appi.ajp.2011.11020219
32. Liemburg, E., Castelein, S., Stewart, R., van der Gaag, M., Aleman, A., & Knegtering, H. (2013). Two subdomains of negative symptoms in psychotic disorders: Established and confirmed in two large cohorts. Journal of Psychiatric Research, 47, 718-725. doi:10.1016/j.jpsychires.2013.01.024
33. Linscott, R. J., Allardyce, J., & van Os, J. (2010). Seeking verisimilitude in a class: A systematic review of evidence that the criterial clinical symptoms of schizophrenia are taxonic. Schizophrenia Bulletin, 36, 811-829. doi:10.1093/schbul/sbn181
34. Malhi, G. S., Green, M., Fagiolini, A., Peselow, E. D., & Kumari, V. (2008). Schizoaffective disorder: Diagnostic issues and future recommendations. Bipolar Disorders, 10, 215-230. doi:10.1111/j.1399-5618.2007.00564.x
35. Mayerhoff, D. L., Loebel, A. D., Alvir, J. M. L., Szymanski, S. R., Geisler, S. H., Borenstein, M., & Lieberman, J. A. (1994). The deficit state in first-episode schizophrenia. American Journal of Psychiatry, 151, 1417-1422. doi:10.1016/0920-9964(92)90270-F
36. Messinger, J. W., Tremeau, F., Antonius, D., Mendelsohn, E., Prudent, V., Stanford, A. D., & Malaspina, D. (2011). Avolition and expressive deficits capture negative symptom phenomenology: Implications for schizophrenia research. Clinical Psychology Review, 31, 161-168. doi:10.1016/j.cpr.2010.09.002
37. Nordgaard, J., Arnfred, S. M., Handest, P., & Parnas, J. (2008). The diagnostic status of first-rank symptoms. Schizophrenia Bulletin, 34, 137-154. doi:10.1093/schbul/sbm044
38. Owoso, A., Carter, C. S., Gold, J. M., Macdonald, A. W., Ragland, J. D., Silverstein, S. M., Barch, D. M. (2013). Cognition in schizophrenia and schizoaffective disorder: Impairments that are more similar than different. Psychological Medicine, 25, 1-11. doi:10.1017/S0033291713000536
39. Peralta, V., & Cuesta, M. J. (1999). Diagnostic significance of Schneider's first-rank symptoms in schizophrenia: Comparative study between schizophrenic and nonschizophrenic psychotic disorders. British Journal of Psychiatry, 174, 243-248. doi:10.1192/bjp.174.3.243
40. Peralta, V., & Cuesta, M. J. (2003). The nosology of psychotic disorders: A comparison among competing classification systems. Schizophrenia Bulletin, 29, 413-425. doi:10.1093/oxfordjournals.schbul.a007016
41. Ramperti, N., Anwar, M., Renwick, L., Jackson, D., Foley, S., McWilliams, S., O'Callaghan, E. (2010). First rank symptoms in first episode psychosis and their relationship to the duration of untreated illness. Journal of Nervous and Mental Disease, 198, 820-823. doi:10.1097/NMD.0b013e3181f97c29
42. Rector, N. A., Beck, A. T., & Stolar, N. (2005). The negative symptoms of schizophrenia: A cognitive perspective. Canadian Journal of Psychiatry, 50, 247-257.
43. Reichenberg, A., & Harvey, P. D. (2007). Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings. Psychological Bulletin, 133, 833-858. doi:10.1037/0033-2909.133.5.833
44. Reichenberg, A., Harvey, P. D., Bowie, C. R., Mojtabai, R., Rabinowitz, J., Heaton, R. K., & Bromet, E. (2009). Neuropsychological function and dysfunction in schizophrenia and psychotic affective disorders. Schizophrenia Bulletin, 35, 1022-1029. doi:10.1093/schbul/sbn044
45. Rounsaville, B., Alarcon, R., Andrews, G., Jackson, J., Kendell, R., & Kendler, K. S. (2002). Basic nomenclature issues for DSM-V. In D. Kupfer, M. First & D. Regier (Eds.), Research agenda for DSM-V (pp. 1-30). Washington, DC: American Psychiatric Association.
46. Schwartz, J. E., Fennig, S., Tanenberg-Karant, M., Carlson, G., Craig, T., Galamboa, N., Bromet, E. J. (2000). Congruence of diagnoses 2 years after a first-admission diagnosis of psychosis. Archives of General Psychiatry, 57, 593-600. doi:10.1001/archpsyc.57.6.593
47. Stahl, S. M., & Buckley, P. F. (2007). Negative symptoms of schizophrenia: A problem that will not go away. Acta Psychiatrica Scandinavica, 115, 4-11. doi:10.1111/j.1600-0447.2006.00947.x
48. Strauss, G. P., Horan, W. P., Kirkpatrick, B., Fischer, B. A., Keller, W. R., Miski, P., Carpenter, W. T. (2013). Deconstructing negative symptoms of schizophrenia: Avolition-apathy and diminished expression clusters predict clinical presentation and functional outcome. Journal of Psychiatric Research, 47, 783-790. doi:10.1016/j.jpsychires.2013.01.015
49. Tandon, R., Bruijnzeel, D., & Rankupalli, B. (2013). Does change in definition of psychotic symptoms in diagnosis of schizophrenia in DSM-5 affect caseness? Asian Journal of Psychiatry, 4, 330-332. doi:10.1016/j.ajp.2013.05.011
50. Tandon, R., Gaebel, W., Barch, D. M., Bustillo, J., Gur, R. E., Heckers, S., Carpenter, W. (2013). Definition and description of schizophrenia in the DSM-5. Schizophrenia Research, 150, 3-10. doi:10.1016/j.schres.2013.05.028
51. Tandon, R., Nasrallah, H. A., & Keshavan, M. S. (2009). Schizophrenia, "just the facts" 4. Clinical features and conceptualization. Schizophrenia Research, 110, 1-23. doi:10.1016/j.schres.2009.03.005
52. Tsuang, M. T., Van Os, J., Tandon, R., Barch, D. M., Bustillo, J., Gaebel, W., Carpenter, W. (2013). Attenuated psychosis syndrome in DSM-5. Schizophrenia Research, 150, 31-35. doi:10.1016/j.schres.2013.05.004
53. Yung, A. R., Phillips, L. J., Yuen, H. P., Francey, S. M., McFarlane, C. A., Hallgren, M., & McGorry, P. D. (2003). Psychosis prediction: 12-month follow up of a high-risk ("prodromal") group. Schizophrenia Research, 60, 21-32. doi:10.1016/S0920-9964(02)00167-6
54. Yung, A. R., Woods, S. W., Ruhrmann, S., Addington, J., Schultze-Lutter, F., Cornblatt, B. A., McGlashan, T. H. (2012). Whither the attenuated psychosis syndrome? Schizophrenia Bulletin, 38, 1130-1134. doi:10.1093/schbul/sbs108